Net profit of Natco Pharma declined 37.47% to Rs 133.00 crore in the quarter ended December 2024 as against Rs 212.70 crore during the previous quarter ended December 2023. Sales declined 37.41% to Rs 474.80 crore in the quarter ended December 2024 as against Rs 758.60 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 474.80 | 758.60 | -37 |
| OPM % | 8.17 | 35.34 | - |
| PBDT | 210.70 | 300.50 | -30 |
| PBT | 163.70 | 256.30 | -36 |
| NP | 133.00 | 212.70 | -37 |